Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Buchanan

Showing results (541-550 of 594) with videos related to

Pageof 60
Sort By:
Journal of Clinical Psychopharmacology|December 31, 2010
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot studyDeanna L Kelly, David A Gorelick, Robert R Conley, et al.
Schizophrenia Bulletin Open|August 18, 2020
A Randomized Clinical Trial of Oxytocin or Galantamine in Schizophrenia: Assessing the Impact on Behavioral, Lexical, and Self-Report Indicators of Social AffiliationKristen R Dwyer, Alexandra M Andrea, Christina L G Savage, et al.
Human Brain Mapping|April 16, 2026
Transdiagnostic Profiles of BOLD Signal Variability in Autism and Schizophrenia Spectrum Disorders: Associations With Cognition and FunctioningMaria T Secara, Zara Khan, Ayesha Rashidi, et al.
Human Brain Mapping|November 29, 2017
Integration of routine QA data into mega-analysis may improve quality and sensitivity of multisite diffusion tensor imaging studiesPeter Kochunov, Erin W Dickie, Joseph D Viviano, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
Transdiagnostic Profiles of BOLD Signal Variability in Autism and Schizophrenia Spectrum Disorders: Associations with Cognition and FunctioningMaria T Secara, Zara Khan, Ayesha Rashidi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 3, 2016
Task-related fMRI responses to a nicotinic acetylcholine receptor partial agonist in schizophrenia: A randomized trialDeanna M Barch, Stephen R Marder, Michael P Harms, et al.
Schizophrenia Bulletin|March 4, 2025
Comparative Analysis of Social Cognitive and Neurocognitive Performance Across Autism and Schizophrenia Spectrum DisordersAyesha G Rashidi, Lindsay D Oliver, Iska Moxon-Emre, et al.
Schizophrenia Bulletin|July 9, 2021
Relations Among Anhedonia, Reinforcement Learning, and Global Functioning in Help-seeking YouthLeeAnn Akouri-Shan, Jason Schiffman, Zachary B Millman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 16, 2020
Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioningPaola Bucci, Armida Mucci, Inge Winter van Rossum, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 12, 2024
Functional magnetic resonance imaging in schizophrenia: current evidence, methodological advances, limitations and future directionsAristotle N Voineskos, Colin Hawco, Nicholas H Neufeld, et al.
Pageof 60

Showing results (541-550 of 594) with videos related to

Sort By:
Pageof 60
Journal of Clinical Psychopharmacology|December 31, 2010
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot studyDeanna L Kelly, David A Gorelick, Robert R Conley, et al.
Schizophrenia Bulletin Open|August 18, 2020
A Randomized Clinical Trial of Oxytocin or Galantamine in Schizophrenia: Assessing the Impact on Behavioral, Lexical, and Self-Report Indicators of Social AffiliationKristen R Dwyer, Alexandra M Andrea, Christina L G Savage, et al.
Human Brain Mapping|April 16, 2026
Transdiagnostic Profiles of BOLD Signal Variability in Autism and Schizophrenia Spectrum Disorders: Associations With Cognition and FunctioningMaria T Secara, Zara Khan, Ayesha Rashidi, et al.
Human Brain Mapping|November 29, 2017
Integration of routine QA data into mega-analysis may improve quality and sensitivity of multisite diffusion tensor imaging studiesPeter Kochunov, Erin W Dickie, Joseph D Viviano, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
Transdiagnostic Profiles of BOLD Signal Variability in Autism and Schizophrenia Spectrum Disorders: Associations with Cognition and FunctioningMaria T Secara, Zara Khan, Ayesha Rashidi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 3, 2016
Task-related fMRI responses to a nicotinic acetylcholine receptor partial agonist in schizophrenia: A randomized trialDeanna M Barch, Stephen R Marder, Michael P Harms, et al.
Schizophrenia Bulletin|March 4, 2025
Comparative Analysis of Social Cognitive and Neurocognitive Performance Across Autism and Schizophrenia Spectrum DisordersAyesha G Rashidi, Lindsay D Oliver, Iska Moxon-Emre, et al.
Schizophrenia Bulletin|July 9, 2021
Relations Among Anhedonia, Reinforcement Learning, and Global Functioning in Help-seeking YouthLeeAnn Akouri-Shan, Jason Schiffman, Zachary B Millman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 16, 2020
Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioningPaola Bucci, Armida Mucci, Inge Winter van Rossum, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 12, 2024
Functional magnetic resonance imaging in schizophrenia: current evidence, methodological advances, limitations and future directionsAristotle N Voineskos, Colin Hawco, Nicholas H Neufeld, et al.
Pageof 60